Increase your success rate at an early stage. With pharmAI's rapid off-target prediction service you can already find potential off-targets during the discovery stage.
Get control over potential off-target complications prior to further investments.
Off target identification covering the human proteome
Drugs may not always only do what we think they do. Many proposed new drug candidates fail clinical trials due to undesired and potentially harmful side-effects resulting in significant scientific and economic risks.
PharmAI’s DiscoveryEngine searches among hundreds of thousands of proteins and drugs for associations and off-targets using a groundbreaking combination of 3D protein structure data and artificial intelligence.